Auxogyn licenses noninvasive embryo assessment technology from Stanford University
Sunday, October 3, 2010 - 12:20
in Mathematics & Economics
Auxogyn, Inc., a privately held medical technology company focused on women's reproductive health, today announced that it acquired an exclusive license from Stanford University to develop a set of products that may allow medical practitioners in the field of assisted reproduction to significantly improve the effectiveness of in vitro fertilization (IVF) procedures.
